Search

everythinglearnresearchcommunity

for

Search:↓

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Finasteride may help reduce anxiety and depression in elderly but might cause depression in young men.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

SLE should be considered in unexplained fevers, even in males.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Dermatologists need to understand African American hair-care practices to better treat their hair and scalp disorders.

Tph cells are linked to the severity of systemic lupus erythematosus.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

People with depression often have higher hair cortisol levels, while those with PTSD tend to have lower levels, but more research is needed to understand this fully.

Hair loss in lupus patients indicates higher disease activity.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.